14-day Premium Trial Subscription Try For FreeTry Free

Short Interest in Forward Pharma A/S (NASDAQ:FWP) Decreases By 31.0%

12:26am, Monday, 20'th Dec 2021 Dakota Financial News
Forward Pharma A/S (NASDAQ:FWP) was the recipient of a significant drop in short interest during the month of November. As of November 30th, there was short interest totalling 73,100 shares, a drop of 31.0% from the November 15th total of 105,900 shares. Approximately 1.1% of the shares of the company are short sold. Based on []

Forward Pharma A/S (NASDAQ:FWP) Sees Large Growth in Short Interest

09:54am, Saturday, 04'th Dec 2021 Dakota Financial News
Forward Pharma A/S (NASDAQ:FWP) was the recipient of a large growth in short interest in the month of November. As of November 15th, there was short interest totalling 105,900 shares, a growth of 39.5% from the October 31st total of 75,900 shares. Currently, 1.6% of the companys stock are sold short. Based on an average []

Short Interest in Forward Pharma A/S (NASDAQ:FWP) Declines By 29.1%

04:50pm, Saturday, 20'th Nov 2021 Transcript Daily
Forward Pharma A/S (NASDAQ:FWP) saw a large drop in short interest in October. As of October 29th, there was short interest totalling 75,900 shares, a drop of 29.1% from the October 14th total of 107,000 shares. Based on an average daily trading volume, of 133,500 shares, the days-to-cover ratio is currently 0.6 days. Approximately 1.1% []

Forward Pharma A/S (NASDAQ:FWP) Stock Passes Above 50 Day Moving Average of $6.76

08:10am, Wednesday, 17'th Nov 2021 Dakota Financial News
Shares of Forward Pharma A/S (NASDAQ:FWP) crossed above its fifty day moving average during trading on Tuesday . The stock has a fifty day moving average of $6.76 and traded as high as $6.77. Forward Pharma A/S shares last traded at $6.58, with a volume of 19,400 shares. The business has a fifty day simple []
The stock price of Forward Pharma A/S (NASDAQ: FWP) fell by almost 20% during the premarket.  Investors are responding negatively to the Technical Board of Appeal (TBA) of the European Patent Offic
The stock price of Forward Pharma A/S (NASDAQ:FWP) fell by over 20% pre-market. This is why it happened.
COPENHAGEN, Denmark, Sept. 06, 2021 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (“we,” “Forward” or the “Company”), today announced that the Technical Board of Appeal (the “TBA�
COPENHAGEN, Denmark, April 14, 2021 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (“We,” “Forward” or the “Company” and, together with its subsidiaries, the “Group”), today repor
COPENHAGEN, Denmark, Jan. 12, 2021 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (“we,” “Forward” or the “Company”), today announced that due to ongoing precautionary measures agains
Chr. Hansen Holding A/S (OTCMKTS:CHYHY) was upgraded by research analysts at Goldman Sachs Group from a “sell” rating to a “neutral” rating in a report issued on Tuesday, The Fly reports. A nu
Chr. Hansen Holding A/S (OTCMKTS:CHYHY) has been assigned a consensus rating of “Hold” from the eight ratings firms that are covering the stock, Marketbeat reports. Three equities research analyst
Denmark stocks higher at close of trade; OMX Copenhagen 20 up 0.65%
Shares of Ascendis Pharma A/S (NASDAQ:ASND) have earned a consensus rating of “Buy” from the fourteen research firms that are presently covering the company, Marketbeat.com reports. One analyst ha
Nuveen Asset Management LLC lowered its position in shares of Ascendis Pharma A/S (NASDAQ:ASND) by 31.3% in the second quarter, according to the company in its most recent disclosure with the SEC. The
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE